Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
Department of Epidemiology, Erasmus Medical Center, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
BMC Prim Care. 2022 Sep 7;23(1):224. doi: 10.1186/s12875-022-01840-6.
To optimize antibiotic treatment and decrease antibiotic resistance, national treatment guidelines are available for urinary tract infections (UTIs) in general practice. The usefulness of these guidelines in risk areas for antimicrobial resistance such as cross border regions or areas with dense agriculture, is unknown.
Midstream urine samples from women with symptoms of acute UTI visiting general practitioners (GPs) in the Westland area, a dense agriculture area, were microbiologically analysed, and patient characteristics, symptoms, previous and present antibiotic treatment were collected. The National Nivel data were used as reference for antibiotic resistance.
Of 310 women with symptoms of uncomplicated UTI, 247 (80%) had a culture proven E. coli UTI. Empirical antibiotic therapy was prescribed to 148 patients (48%) in total; in 7% of women with a negative and 52% with a positive urine culture. Having more than one symptom was associated with the prescription of antibiotics; travel history or previous antibiotic use for UTI were not. The isolated uropathogens were susceptible to the empiric antibiotic therapy in 98% of patients. Resistance to co-amoxiclav was higher (22%) than reported in the national data of 2004 (12%), 2009 (13%) and 2014 (9%), as was the prevalence of extended spectrum β-lactamase (ESBL): 3.4% in our study versus 0.1%, 1% and 2.2% in the national data respectively.
The presence of environmental and socio-demographic risk factors for antibiotic resistance did not influence the empiric choice nor susceptibility for antibiotics advised by the national guidelines in women with uncomplicated UTI.
为了优化抗生素治疗并降低抗生素耐药性,一般实践中提供了针对尿路感染(UTI)的国家治疗指南。这些指南在抗生素耐药风险地区(如跨境地区或农业密集地区)的有用性尚不清楚。
从西兰德地区(一个农业密集地区)有急性 UTI 症状的女性的中段尿样进行微生物分析,并收集患者特征、症状、以前和现在的抗生素治疗情况。国家 Nivel 数据被用作抗生素耐药性的参考。
在 310 名有单纯性 UTI 症状的女性中,247 名(80%)有培养证实的大肠埃希菌 UTI。共有 148 名患者(48%)接受了经验性抗生素治疗;在阴性尿培养的女性中占 7%,在阳性尿培养的女性中占 52%。有多个症状与开抗生素处方有关;旅行史或以前因 UTI 使用抗生素与开抗生素无关。98%的患者分离的尿路病原体对经验性抗生素治疗敏感。与 2004 年(12%)、2009 年(13%)和 2014 年(9%)的全国数据相比,对复方新诺明的耐药率较高(22%),而对扩展谱β-内酰胺酶(ESBL)的流行率也较高:本研究为 3.4%,而全国数据分别为 0.1%、1%和 2.2%。
环境和社会人口危险因素的存在并未影响国家指南建议的女性单纯性 UTI 的经验性抗生素选择或抗生素敏感性。